Imunon Inc (IMNN) Stock Analysis

Imunon Inc (IMNN) is a publicly traded company in the HEALTHCARE sector. It trades at $2.14, carries a market capitalization of $9.03M. This page summarizes the public market data, fundamentals, and frequently asked questions for IMNN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.14
• Market Cap: $9.03M
• EPS: $-4.52
• 52-Week High: $24.05
• 52-Week Low: $2.08

Market Sentiment

Imunon Inc currently has a Neutral sentiment score of 0.04.

About Imunon Inc

None

GNG Research Analysis

GNG Research scores Imunon Inc (IMNN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IMNN.

Frequently Asked Questions

Does IMNN pay dividends?

Imunon Inc (IMNN) does not currently pay a regular dividend.

What is IMNN's market cap?

Imunon Inc (IMNN) has a market capitalization of $9.03M with a current stock price of $2.14.